A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting the spread ...

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors ...

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells ...

You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than ...

Scientists know that colorectal cancer cells require large amounts of iron and that as cancer becomes more aggressive, the ...

Inter-patient tumor heterogeneity refers to transcriptional differences between cancer cells of different patients. Because of their distinct mutational histories, spatial location and interactions ...

Most cancers originate from genetic abnormalities, specifically the accumulation of somatic mutations. These mutations accumulate in normal cells in all organs of healthy individuals and are driven by ...

A hallmark of cancerous cells is an abnormal number of chromosomes or chromosome arms, known as aneuploidy. While aneuploidy is detrimental to regular cells, it occurs in as many as 90% of tumors. How ...

A newly identified loss of cellular identity may enable colorectal cancer cells to enter a highly flexible state that promotes liver metastasis.

A comprehensive multi-cancer study by researchers at The University of Texas MD Anderson Cancer Center has revealed that ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer. This molecule ...